Boston Scientific unit faces charges over defibrillators

02/25/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

The Department of Justice on Thursday accused Guidant, a Boston Scientific unit, of not informing the FDA of failures in three models of implantable defibrillators, which have been linked to at least seven deaths. A spokesman for Boston Scientific said, "We continue to believe that Guidant and its employees acted in good faith and with the intention of complying with applicable laws and regulations."

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX